Literature DB >> 29565399

Deadly Lassa-fever outbreak tests Nigeria's revamped health agency.

Amy Maxmen.   

Abstract

Mesh:

Year:  2018        PMID: 29565399     DOI: 10.1038/d41586-018-03171-y

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays.

Authors:  Yíngyún Caì; Masaharu Iwasaki; Brett F Beitzel; Shuīqìng Yú; Elena N Postnikova; Beatrice Cubitt; Lisa Evans DeWald; Sheli R Radoshitzky; Laura Bollinger; Peter B Jahrling; Gustavo F Palacios; Juan C de la Torre; Jens H Kuhn
Journal:  Viruses       Date:  2018-11-20       Impact factor: 5.818

Review 2.  Validating Joint External Evaluation reports with the quality of outbreak response in Ethiopia, Nigeria and Madagascar.

Authors:  Richard Garfield; Maureen Bartee; Landry Ndriko Mayigane
Journal:  BMJ Glob Health       Date:  2019-12-29

3.  Reviewing Health Security Capacities in Nigeria Using the Updated WHO Joint External Evaluation and WHO Benchmarks Tool: Experience from a Country-Led Self-Assessment Exercise.

Authors:  Olukayode Fasominu; Oyeladun Okunromade; Oyeronke Oyebanji; Christopher T Lee; Adejare Atanda; Ibrahim Mamadu; Ifeanyi Okudo; Ebere Okereke; Elsie Ilori; Chikwe Ihekweazu
Journal:  Health Secur       Date:  2022-01-11

Review 4.  Lassa fever - the road ahead.

Authors:  Robert F Garry
Journal:  Nat Rev Microbiol       Date:  2022-09-12       Impact factor: 78.297

5.  The Role of Receptor Tyrosine Kinases in Lassa Virus Cell Entry.

Authors:  Chiara Fedeli; Hector Moreno; Stefan Kunz
Journal:  Viruses       Date:  2020-08-06       Impact factor: 5.048

6.  Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.

Authors:  Peilin Wang; Yang Liu; Guangshun Zhang; Shaobo Wang; Jiao Guo; Junyuan Cao; Xiaoying Jia; Leike Zhang; Gengfu Xiao; Wei Wang
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.